|
||||||
BEIJING (Feb. 13, 2014) — The International Service for the Acquisition of Agri-Biotech Applications (ISAAA) today released a report which indicates more than 18 million farmers in 27 countries planted biotech crops in 2013, reflecting a five million, or three percent, increase in global biotech crop hectarage. 2013 also marks the first-ever commercial plantings of drought-tolerant biotech maize in the United States. Global biotech crop hectarage has increased from 1.7 million hectares in 1996 to over 175 million hectares in 2013. During this 18 year period, more than a 100-fold increase of commercial biotech crop hectarage has been reported. The United States continues to lead global biotech crop plantings at 70.1 million hectares or 40 percent of total global hectares. “Accumulated hectarage of biotech crops planted worldwide to-date stands at 1.6 billion hectares or 150 percent of the total landmass of China,” said Clive James, author of the report and ISAAA Founder and Chairman Emeritus. “Each of the top ten countries planting biotech crops during 2013 planted more than one million hectares, providing a broad foundation for future growth.” According to the report, more than 90 percent, or 16.5 million, of farmers planting biotech crops are small and resource-poor. Of the countries planting biotech crops, eight are industrial countries and 19 are developing countries. For the second year, developing countries planted more hectares of biotech crops than industrialized countries, representing confidence and trust of millions of risk-adverse farmers around the world that have experienced the benefits of these crops. Nearly 100 percent of farmers who try biotech crops continue to plant them year after year, the report notes. Two new drought-tolerant crops “Biotech crops are demonstrating their global value as a tool for resource poor farmers who face decreased water supplies and increased weed and pest pressures – and the effects of climate change will only continue to expand the need for this technology,” said James. Biotech drought-tolerant maize technology has been donated to Africa through the Water Efficient Maize for Africa (WEMA) project, a public/private partnership by Monsanto and BASF, funded by the Gates and Buffet foundations and implemented through the International Maize and Wheat Improvement Center (CIMMYT) in Mexico and Kenya-based African Agricultural Technology Foundation (AATF). Planting of biotech drought-tolerant maize in Africa is expected in 2017. Drought is the biggest constraint to maize productivity in Africa on which 300 million Africans depend for survival. Status and opportunities for biotech crops in China “China has already experienced the benefits of biotech cotton for fiber, and could also benefit from biotech maize through increased and improved grain production for animal feed,” said James. “China could also benefit from the approval of biotech traits for rice, the staple food crop in Asia.” Some observers speculate China might be paving the way to approval of a major biotech crop, like the phytase-maize that received biosafety clearance in 2009, when two biotech rice traits were also approved. The feed demand of sustaining China’s 500 million swine and 13 billion poultry is causing the country to become increasingly reliant on imported maize, to supplement the 35 million hectares of maize it grows. Increased hectarage in developing countries South America collectively planted 70 million hectares or 41 percent; Asia collectively planted 20 million hectares or 11 percent; and Africa collectively planted just over 3 million hectares or two percent of the global biotech hectarage. “Growth in industrial countries and mature markets in developing countries continued to plateau in 2013 as adoption rates were sustained at 90 percent or more, leaving little room for expansion,” said James. “During the past year, growth was led by developing countries, namely Brazil, which posted an impressive 3.7 million hectare or 10 percent increase, reaching 40.3 million total hectares. During the next year, growth is expected to continue in developing countries – and Brazil will continue to lead the way, consistently closing the gap with the United States.” Success in developing countries can often be attributed to public/private partnerships. For example, Brazil, in cooperation with BASF, has developed and approved a herbicide-tolerant soybean that is ready for commercialization, having successfully completed all steps necessary for development and deployment of the product. Such partnerships instill pride which generates confidence and incentive necessary for success. EMBRAPA in Brazil, using entirely national resources, has also developed and achieved approval of virus-resistant beans, which is an important contribution to sustainability. Breaking the impasse to approve biotech crops
Continued developments in biotech crop technology combined with increased adoption by small and poor farmers are important factors in the future of global biotech crop adoption. Substantial developments in 2013 include:
The lack of appropriate, science-based, cost- and time-effective regulatory systems continues to be the major constraint to adoption in Africa (and across the world). Status of biotech crops in the European Union Biotech crops benefit food security, sustainability and the environment By the numbers
*Information about ISAAA and the author The International Service for the Acquisition of Agri-biotech Applications (ISAAA) is a not-for-profit organization with an Further information about ISAAA can be obtained from its website www.isaaa.org. Please contact the ISAAA Center in SouthEast Asia: e-mail publications@isaaa.org for your copy of Brief 46. You may purchase a copy on-line at http://www.isaaa.org/purchasepublications/ for US$50. This includes a hard copy of the full version of Brief 46, Executive Summary, and Top Ten Facts. The publication is available free of charge to eligible nationals of developing countries. |
||||||
Do not hesitate to tell other colleagues/contacts about this mail list. If they wish to join, they may do so at http://www.isaaa.org/subscribe If you will be changing your e-mail address soon, please update your subscription preferences to continue receiving the Crop Biotech Update. Please visit Crop Biotech Update web pages (http://www.isaaa.org/kc) to view previous issues of this newsletter and see other available resources for download. |
||||||